Answers are grounded in this paper and cite their sources.
: BBB opening via sonopermeation enables safe and efficient delivery of nanomedicine formulations to and into the brain. When looking at accumulation and penetration (and when neglecting issues such as drug loading capacity and therapeutic efficacy) smaller-sized DDS are found to be more suitable for drug delivery across the BBB than larger-sized DDS. These findings are valuable for better understanding and further developing nanomedicine-based strategies for the treatment of CNS disorders.
No takes yet. Share an insight, caveat, or question.
May et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: